Status:
TERMINATED
Automated Method for Breast Cancer Detection
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions:
Breast Cancer Diagnosis
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Participants with suspicious breast lesions by mammography will undergo fine needle aspiration (FNA) under ultrasound guidance. The FNA will be read by the cytopathologist and analyzed in the breast c...
Eligibility Criteria
Inclusion
- Patient must be female
- Patient must be 18 years of age or older
- Patient has been recommended for ultrasound core needle biopsy of a suspicious breast lesion
Exclusion
- Patients may be excluded for any condition that in the opinion of the investigator may not make it safe to take part (e.g. certain medicines).
Key Trial Info
Start Date :
March 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2020
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT03863522
Start Date
March 7 2019
End Date
December 15 2020
Last Update
November 19 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital Outpatient Center
Baltimore, Maryland, United States, 21287
2
Johns Hopkins Medical Imaging at Green spring Station
Lutherville-Timonium, Maryland, United States, 21093